MedPath

Comparing the efficacy of bupropion and amantadine on sexual dysfunction induced by a selective serotonin reuptake inhibitor

Not Applicable
Conditions
Sexual dysfunction.
Sexual dysfunction, not caused by organic disorder or disease
Registration Number
IRCT201409275280N17
Lead Sponsor
Vice Chancellor for research of Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
38
Inclusion Criteria

Inclusion criteria: patients who had a diagnosis of Major depression disorder; were in remission while taking a stable dose of Selective Serotonin Reuptake Inhibitors for at least 8 weeks;
exclusion criteria:patients with any previous sexual dysfunction ; relapse of major depression;body mass index of = 30 kg/m; had a sexual partner with a history of sexual dysfunction.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sexual dysfunction. Timepoint: Baseline and 4 weeks after treatment. Method of measurement: Arizona Sexual Experience Scale (ASEX).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath